We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

Trimeris

Website: www.trimeris.com/910ContactUs.aspx

Telephone Number: 919-806-4682

Approved Drugs:

Fuzeon (enfuvirtide) — Entry inhibitor

Drugs in Pre-approval Status:

TRI-1144 (TR-0291144)—Next Generation Entry Inhibitor

Comment: An IND was filed in January 2008 for the clinical study of TRI-1144. Currently, one clinical protocol is in progress (TRI 1144-101). TRI 1144-101 is a single dose escalation study in healthy volunteers that is investigating the safety, including injection site reactions, tolerability and pharmacokinetics of TRI-1144.